NCDHHS Says October Asheboro Clinic Will Be North Carolina's 100th Opioid Treatment Program; Suspected Overdose Deaths Down More Than 23% in the First Half of 2026
State health officials announced federal approval of an Acadia Healthcare clinic in Randolph County and released midyear data showing fewer suspected overdose deaths and fewer overdose emergency room visits than in the same period of 2025.
Two Numbers, One Announcement, Three Different Explanations
On August 31, 2026, North Carolina's health department said something that sounds simple: the state is about to have its 100th opioid treatment program. Federal regulators certified a clinic in Asheboro on August 19, and it opens in October[1]. Once it does, North Carolina will have 100 fixed clinics plus three mobile units, reaching 57 of its 100 counties — about one program for every 109,000 people[1].
In the same release, the state reported that suspected overdose deaths fell more than 23% in the first half of 2026 compared with the same period last year. Emergency room visits for overdoses dropped 18% over that stretch[1]. Those numbers build on something real: confirmed deaths fell from 4,442 in 2023 to 2,934 in 2024, a 34% drop and the state's first annual decline since 2019[2].
Almost nobody disputes that the numbers are moving in the right direction. What's contested is why, and who gets to say so. The state's own release puts a clinic count and a death count side by side without ever claiming one caused the other[1]. Everyone reading it has since felt free to fill in that blank.
What Methadone Clinics Actually Do, and Why They're Locked Up Tight
To understand the fight, you need to understand the clinic itself. Methadone and buprenorphine are medicines used to treat opioid addiction, and they have the strongest evidence of any treatment for keeping people alive. But methadone is also an opioid. Taken wrong, especially in the first weeks, it can kill.
That's why federal law says methadone can only be dispensed at a licensed opioid treatment program, or OTP — not at a regular pharmacy. Patients typically show up daily to be dosed under supervision, alongside counseling and drug testing. Supporters call this the safety design that makes the medicine usable at all.
But that same rule means geography decides who gets treated. If there's no clinic within driving distance, methadone might as well not exist for you. Going from a patchy map to 100 clinics in 57 counties closes some of those gaps[1] — but 43 counties will still have none[1].
The rule also happens to be a business moat. Only licensed OTPs can dispense methadone, which means the clinic operators have no competition from pharmacies. A bipartisan bill from Senators Ed Markey and Rand Paul would loosen that rule; the industry, including trade groups representing operators, opposes it in safety terms while also standing to lose revenue if it passes[11][12]. Both things can be true at once — the supervision argument is real, and so is the financial stake in keeping it as the only pathway to the medicine.
Who Runs Clinic Number 100
The clinic opening in October will be run by Acadia Healthcare, the largest chain of methadone clinics in the country[1][3]. That fact doesn't appear in North Carolina's press release, and it's largely absent from local coverage of the milestone.
It matters because Acadia has been under scrutiny. Reporting from the New York Times, syndicated by the Seattle Times, found that some Acadia clinics falsified records, enrolled patients who didn't actually have opioid use disorder, and ran counselor caseloads more than double state limits — while directors got bonuses tied to enrollment growth[3]. Senator Markey's office has separately raised concerns about the company's profit incentives and their effect on patient care[4].
The fallout has been real. The Justice Department and the Department of Veterans Affairs both opened investigations[3][4]. Acadia's stock lost roughly half its value, wiping out around $4 billion in market value[3].
None of that means the Asheboro clinic will operate the same way its troubled counterparts reportedly did. But it does mean that "100 clinics" measures capacity, not necessarily quality — a clinic can exist, be certified, and still not deliver the counseling and oversight the model depends on.
Border Enforcement or Medicaid: Two Camps, One Falling Line
Zoom out to the national numbers, and the fight over credit gets louder. Overdose deaths nationally fell from 81,313 in 2024 to 69,973 in 2025 — a 14% drop. Deaths tied to synthetic opioids like fentanyl fell 22%, from 48,913 to 38,084[7].
The Trump administration and right-leaning outlets point to border enforcement and cartel crackdowns as the reason. Fox News reported figures supplied directly by the White House, framing the decline around stepped-up interdiction[7][8]. Their case has real logic behind it: fentanyl is largely imported, so choking the supply chain would plausibly show up in a national death curve. The Washington Times ran similar numbers under a headline that conceded the causes are still disputed[9].
Public health researchers and Democratic-aligned analysts point somewhere else: naloxone distribution, expanded treatment capacity, and Medicaid coverage. In North Carolina, more than 675,000 people had enrolled through Medicaid expansion as of August 2025, and over half of Medicaid patients treated for opioid use disorder in 2023 got there because of that expansion[10]. Their argument is that an open clinic doesn't help anyone who can't afford to walk through the door — and Medicaid is what pays for most addiction treatment in the country.
That argument comes with a warning attached. Researchers project that Medicaid cuts under the One Big Beautiful Bill Act could cost 156,000 people nationally their medication and cause more than 1,000 additional overdose deaths a year[10]. The Centers for Disease Control and Prevention has said multiple factors are likely contributing at once and hasn't ranked them[7].
The Number Under the Number
Statewide averages can hide what's happening in a specific place. WRAL reported that opioid overdoses recorded in North Carolina emergency departments fell 27% in the first half of 2026 — to 2,031 visits, more than 700 fewer than the same period a year earlier[5]. That's a different measurement than the state's 23% death-decline figure, tracking ER visits rather than deaths, which is why the two numbers don't match.
At the same time, Fayetteville police warned in August that suspected fentanyl overdoses in the city had already hit 24 by midyear — matching the city's entire count for all of 2025[5][6]. Officials said that could point to an unusually potent or contaminated batch of drugs circulating locally.
So the statewide trend and a local emergency are running at the same time, in the same state, in the same data set. Neither cancels the other out.
What Nobody Involved Is Actually Claiming
Strip away the competing explanations, and a few things hold up regardless of who's right. Overdose deaths in North Carolina are falling, and the decline has lasted across multiple years, not just one good quarter[1][2]. The 2026 figures are still preliminary — "suspected" deaths get revised once toxicology results come back, so the 23% figure could shift.
Forty-three counties will still lack any opioid treatment program once the Asheboro clinic opens[1]. The company running that clinic is under federal investigation over how it has run others[3][4]. And the funding that pays for most of this treatment, Medicaid, is facing cuts that researchers say would reverse at least some of the progress[10].
North Carolina's own press release doesn't claim to have solved the causation question, and neither does anyone else with hard evidence. What's left is a genuine reduction in suffering, several groups with real reasons to want credit for it, and a system whose next chapter — more clinics, tighter enforcement, or thinner Medicaid rolls — hasn't been written yet.
Summary
North Carolina's health agency said on August 31, 2026 that a new clinic in Asheboro will be the state's 100th opioid treatment program, or OTP[1]. An OTP is a federally licensed clinic — the only kind of place in the United States allowed to dispense methadone for addiction treatment. Federal regulators at the Substance Abuse and Mental Health Services Administration certified the clinic on August 19. It is scheduled to open in October. It will be run by Acadia Healthcare, the largest methadone clinic chain in the country[1][3].
In the same announcement, NCDHHS said suspected drug overdose deaths in the state fell more than 23% in the first six months of 2026 compared with the same six months of 2025. Overdose visits to emergency rooms fell 18% over the same stretch[1]. Those are partial-year numbers, and "suspected" deaths are preliminary counts that get revised as toxicology comes back. The most recent finished count is from 2024: 2,934 overdose deaths, down from 4,442 in 2023 — a 34% drop and the first decline since 2019[2].
Almost nobody disputes the direction of the numbers. The dispute is over what deserves the credit, and it splits along familiar lines. The Trump White House and right-leaning outlets point to border enforcement and cartel crackdowns, citing a 22% drop in fentanyl-linked deaths nationally between 2024 and 2025[7][8]. Public-health researchers and Democratic-aligned analysts point to Medicaid expansion, naloxone distribution and treatment capacity, and warn that Medicaid cuts in the One Big Beautiful Bill Act will reverse the gains[10]. The CDC has said several factors contributed at once and has not ranked them[7].
A second, quieter dispute sits underneath the milestone. Counting clinics measures capacity, not care. Acadia, which will operate the 100th clinic, faces federal investigations after reporting found falsified records and counselor caseloads more than double state limits at some of its clinics[3][4]. And the statewide average hides local trouble: as the state number fell, Fayetteville police warned that suspected fentanyl overdoses had already matched the city's entire 2025 total by midyear[5][6].
The Event
On August 31, 2026, the North Carolina Department of Health and Human Services announced that the Asheboro Comprehensive Treatment Center, in Randolph County, will become the state's 100th opioid treatment program when it opens in October[1]. The federal Substance Abuse and Mental Health Services Administration certified the clinic on August 19[1]. NCDHHS said the state will then have 100 fixed clinics plus three mobile units, operating in 57 of the state's 100 counties — roughly one program per 109,000 residents[1]. In the same release, the agency reported that suspected overdose deaths fell more than 23% and overdose-related emergency department visits fell 18% in the first half of 2026 versus the first half of 2025[1].
Undisputed Facts
- SAMHSA certified the Asheboro Comprehensive Treatment Center on August 19, 2026, and NCDHHS says it will open in October as the state's 100th opioid treatment program[1].
- The Asheboro clinic will be operated by Acadia Healthcare, the largest chain of methadone clinics in the United States[1][3].
- North Carolina will have 100 fixed opioid treatment programs plus three mobile units, located in 57 of its 100 counties — about one program for every 109,000 residents[1].
- NCDHHS reported suspected overdose deaths fell more than 23% and overdose emergency department visits fell 18% in the first half of 2026 compared with the first half of 2025[1].
- Confirmed overdose deaths in North Carolina fell from 4,442 in 2023 to 2,934 in 2024, a 34% drop and the first annual decline since 2019[2].
- WRAL reported that emergency departments statewide recorded 2,031 opioid overdoses from January through June 2026, more than 700 fewer than in the same months of 2025 — a 27% decline in that specific measure[5].
- Fayetteville police warned in August 2026 of a local spike, saying suspected fentanyl overdoses had reached 24 by midyear, matching the city's full-year 2025 total[5][6].
- The Justice Department and the Department of Veterans Affairs opened investigations into Acadia Healthcare after reporting that clinics falsified records and enrolled patients without opioid use disorder[3][4].
- More than 675,000 North Carolinians had enrolled through Medicaid expansion as of August 2, 2025, and over half of Medicaid beneficiaries treated for opioid use disorder in 2023 were expansion enrollees[10].
- Nationally, drug overdose deaths fell from 81,313 in 2024 to 69,973 in 2025, and synthetic opioid deaths fell from 48,913 to 38,084[7].
The Pressure
Strip away the moralizing and blame. What structural realities persist regardless of which narrative wins?
- Countable outputs beat contested outcomes
- An agency cannot prove it caused a mortality decline, but it can count clinics. So the clinic count becomes the public measure of success, even though it says nothing about whether the counseling, dosing and follow-up inside those clinics actually happen[1][3].
- The methadone monopoly is a business model
- Federal law confines methadone dispensing to licensed opioid treatment programs. That rule is simultaneously a patient-safety design and a legal moat around an industry. Any move toward pharmacy dispensing — as the Markey-Paul bill proposes — threatens the revenue of the same chains that are opening the new clinics, which is why incumbent providers oppose it while framing the objection in safety terms[11][12].
- Medicaid is the actual funding pipe
- Medicaid is the largest payer for addiction treatment in the country, and in North Carolina expansion enrollees made up more than half of Medicaid patients treated for opioid use disorder in 2023[10]. Clinic capacity and insurance coverage are two separate constraints; adding clinics does nothing if coverage contracts.
- Political ownership of a falling curve
- Overdose deaths began falling before the current administration's enforcement push and kept falling through it. Because no single cause is provable, the trend is available to whoever claims it first and loudest — which is why the White House released figures on a themed awareness day and why state agencies pair milestones with mortality data[7][8].
Material realityOverdose deaths in North Carolina are falling, and the fall is large and sustained: 4,442 deaths in 2023, 2,934 in 2024, and a further drop of more than 23% in suspected deaths through the first half of 2026[1][2]. The 2026 figures are preliminary and cover half a year; final counts typically shift as toxicology results come in. Regardless of who gets credit, three things stay true on the ground. Forty-three of North Carolina's 100 counties will still have no opioid treatment program after the Asheboro clinic opens[1]. The chain running that clinic is under federal investigation over the quality of care inside its existing ones[3][4]. And local outbreaks continue independent of the state average — Fayetteville hit its entire 2025 count of suspected fentanyl overdoses by June 2026[5][6]. Meanwhile the coverage that pays for most of this treatment faces federal cuts that researchers project would push overdose deaths back up[10].
Narrative as a weaponThree groups are actively shaping how this milestone reads. NCDHHS wants you to connect capacity to survival — the release puts a clinic count and a mortality drop in the same headline and lets the word "as" imply the rest[1]. The White House and right-leaning outlets want you to credit interdiction, and the strongest version of that case is real: fentanyl is imported, and supply-side pressure would show up in exactly this kind of national curve[7][8]. Public-health researchers and Democratic-aligned analysts want you to credit Medicaid and naloxone, partly because it is the explanation the evidence best supports on their reading and partly because it is the argument that protects the funding now at risk[10]. Acadia Healthcare is the quietest player and the one with the most immediate use for the story: a clinic-count milestone is favorable coverage arriving while DOJ and VA investigations into its record-keeping are open[3][4]. The one framing no camp is pushing is the simplest: nobody has isolated the cause, and the state's own release does not claim to have.
How Each Side Sees It
Each major actor’s view — how it frames things, its underlying incentive, and how it’s materially affected. Tap a side to read it.
Frames it asThe agency's case is that treatment capacity is the thing a state can actually control, and that building it works. Methadone and buprenorphine — the medicines these clinics dispense — are the treatments with the strongest evidence for keeping people with opioid addiction alive. But methadone can only be given out at a federally licensed clinic, which means geography is destiny: if there is no clinic within driving distance, the treatment effectively does not exist for you. Going from a patchy map to 100 clinics plus three mobile units in 57 counties closes those gaps[1]. NCDHHS presents the falling death numbers alongside that buildout without formally claiming the buildout caused it[1][2].
WhyA state agency benefits from a clean, countable milestone. "100th clinic" is a number a governor can say in a speech, and it demonstrates return on the opioid settlement money and Medicaid expansion the state has committed to substance-use treatment[10].
Impact on themNCDHHS's budget and its authority over behavioral health depend on showing the strategy is working. Federal Medicaid changes under the One Big Beautiful Bill Act would fall on the same programs, so the agency has a direct stake in the record it is building now[10].
Frames it asThe industry's strongest argument is that the clinic model is a bundle, not a vending machine. A patient gets the medicine, plus counseling, plus drug testing, plus daily observed dosing that keeps take-home methadone from being diverted or misused. Methadone is itself an opioid and can kill in overdose, especially in the first weeks of treatment — the supervision is the safety feature, not red tape. Providers argue that letting pharmacies dispense methadone would strip the wraparound care away and point to an uptick in methadone-involved overdose deaths as a reason for caution[11][12]. For-profit operators also argue they are the only entities willing to open clinics in rural counties nonprofits have skipped.
WhyAcadia is a publicly traded company. Each clinic is recurring revenue, largely from Medicaid, and each new certification is growth. It also has a direct financial interest in methadone staying locked to the clinic system, because pharmacy dispensing would remove its monopoly on the medication[3][11].
Impact on themAcadia's stock fell by about half — roughly $4 billion in market value — after the investigations and weaker-than-expected patient volumes became public[3]. It is under DOJ and VA investigation over record falsification and enrollment practices[3][4]. Opening the state's 100th clinic puts it back in a favorable headline while those probes continue.
Frames it asTheir argument is about supply, not demand. Fentanyl is imported, mostly through the southern border and precursor chains, so choking the supply is the intervention that scales. They point to timing: overdose deaths fell 14% nationally between 2024 and 2025 and fentanyl-specific deaths fell 22%, alongside stepped-up border enforcement, cartel designations and trafficker arrests[7][8]. The deeper principle is that treatment capacity manages an epidemic while enforcement ends one — a clinic helps the person already addicted, but interdiction stops the next person from ever getting the drug.
WhyOwnership of the single most favorable public-health trend line of the term. Fentanyl deaths are an issue where the administration polls well and wants the causal credit locked in before the midterms[8].
Impact on themThe same administration's Medicaid changes are what critics say will cut treatment access[10]. That is the bind: it is claiming credit for the decline while being blamed in advance for reversing it.
Frames it asTheir case is that the decline started before the current enforcement push and is best explained by things that reach people directly: naloxone in ordinary hands, more people on methadone and buprenorphine, and insurance that pays for it. Medicaid is the largest payer for addiction treatment in the country. In North Carolina, more than half of Medicaid patients treated for opioid use disorder in 2023 were people who only had coverage because of expansion[10]. Take the coverage away and the clinic count stops mattering — an open clinic you cannot pay for is a closed clinic. Researchers project Medicaid cuts under the OBBBA could cost 156,000 people nationally their medication and cause more than 1,000 extra overdose deaths a year[10].
WhyProtecting Medicaid funding and the harm-reduction framework, and preventing the enforcement-only account from becoming the accepted history of why deaths fell.
Impact on themTheir programs and grants sit downstream of the Medicaid dollars now in question[10].
Frames it asThe people closest to the ground argue that a statewide average is not a description of any actual place. Fayetteville police warned in August that suspected fentanyl overdoses had already matched the city's entire 2025 total by midyear, which they said suggests an unusually potent or contaminated batch circulating locally[5][6]. Forty-three of North Carolina's 100 counties still have no opioid treatment program at all[1]. And patients say the number of clinics is the wrong metric — what matters is whether you get counseling, whether the counselor has time for you, and whether daily dosing is compatible with holding a job.
WhyLocal departments need resources and attention that a good statewide headline can pull away. Patients want treatment that fits a working life.
Impact on themA person in one of the 43 counties without a program still drives to another county, sometimes daily, to get dosed. That is the practical meaning of the map NCDHHS published[1].
Like this article?
The Bias Ledger average rating 4.7
The same story, as framed by outlets across the spectrum, ordered least to most biased. The bias score (1 = straight, 10 = heavily spun) is an AI assessment of that framing — click an outlet to see its track record. The tell is the word choice or omission that reveals the angle.
| Outlet | Vantage | Bias | How they frame it | The tell |
|---|---|---|---|---|
| WRAL | U.S. center; Raleigh commercial broadcaster | 2 | "Recorded overdoses in NC down 27% midway through 2026. Local departments warn of fentanyl spike" | Deliberately splits the good number from the bad one in a single headline. Uses a different metric than the state release — emergency-department opioid overdoses, not deaths — which produces 27% instead of 23%; readers comparing the two figures may not notice they measure different things. |
| The New York Times | U.S. center-left | 3 | Investigation into Acadia Healthcare: the largest U.S. methadone chain falsifies records and enrolls patients who do not have opioid use disorder | Frames clinic growth as a profit-driven system with weak oversight. The reporting is document-based and specific — caseloads above state limits, enrollment-linked director bonuses — but the emphasis on for-profit motive leaves less room for the industry's safety-bundle argument for the clinic model. |
| PolitiFact | U.S. center-left fact-checking operation (Poynter Institute) | 4 | "Maine drug overdoses are down. Is Vance right that Trump's border policies are the cause?" | Concedes the decline outright, then contests only the causal attribution — the standard structure of a fact-check aimed at a Republican claim. Applies more scrutiny to the enforcement explanation than to the treatment-access explanation, which is also not proven. |
| Hoodline | U.S. local aggregator, substantially AI-assisted summarization of press releases | 5 | "Asheboro Clinic Becomes NC's 100th Opioid Treatment Site as Overdose Deaths Plunge" | "Plunge" is a characterization the state release does not use. The piece tracks the NCDHHS announcement closely and adds no independent reporting — notably no mention of who operates the clinic or of Acadia's federal investigations. |
| NCDHHS | North Carolina state agency (executive branch); the subject of the story | 6 | "100th Opioid Treatment Program Coming to North Carolina as NCDHHS Continues to Reduce Overdose Deaths, Emergency Department Visits" | The word "as" does the work of a causal claim without making one. The headline says the agency "continues to reduce" deaths — putting the agency in the subject position of a sentence about a trend with many disputed causes. The release also does not name Acadia's federal investigations. |
| Cato Institute | U.S. libertarian think tank | 6 | "A New Methadone Playbook: How DOGE and Deregulation Can Save Lives" | Argues the clinic system itself is the barrier — that counting clinics is the wrong metric because methadone should be at any pharmacy. Frames incumbent clinic operators as rent-seekers, which is a real argument but also elides the supervision-and-diversion case those operators make. |
| Fox News | U.S. right | 7 | "Fentanyl-linked deaths drop 22% as Trump credits his border crackdown" and "US drug overdose deaths plummet 20% as Trump administration cracks down on southern border" | The numbers were supplied directly by the White House and framed around a presidential anniversary event. "As" again carries an unproven causal claim. CDC's own list of contributing factors — naloxone, treatment access, a shifting drug supply — appears well below the enforcement framing. |
References
- 100th Opioid Treatment Program Coming to North Carolina as NCDHHS Continues to Reduce Overdose Deaths, Emergency Department Visits — NCDHHS · North Carolina state executive agency; the announcing party
- New Data Shows All-Time-Low Infant Mortality in NC, Sharp Decrease in Overdose-Related Deaths — NCDHHS · North Carolina state executive agency
- Fraud and fakery at the country's largest chain of methadone clinics — The New York Times · U.S. center-left national newspaper; investigative desk (read via Seattle Times syndication)
- Senator Markey Raises Concerns Regarding Acadia Healthcare's Profit Motivations, Impact on Patient Care — Office of U.S. Senator Ed Markey · Democratic U.S. senator's official communications
- Recorded overdoses in NC down 27% midway through 2026. Local departments warn of fentanyl spike — WRAL · U.S. center; Raleigh commercial television and news site
- Fayetteville police warn of suspected fentanyl overdose spike — CBS 17 · U.S. center; Nexstar-owned local broadcaster
- US drug overdose deaths plummet 20% as Trump administration cracks down on southern border — Fox News · U.S. right; figures supplied by the White House
- Fentanyl-linked deaths drop 22% as Trump credits his border crackdown — Fox News · U.S. right; exclusive based on administration-provided data
- Overdose deaths drop 20% under Trump, though causes remain disputed — The Washington Times · U.S. right; conservative-owned Washington daily
- Drug Overdose Trends in North Carolina and Potential Impacts of the One Big Beautiful Bill Act (OBBBA) — North Carolina Institute of Medicine · State-chartered health policy body; funded largely by foundation and state grants, generally aligned with Medicaid-expansion advocacy
- Methadone Was Locked to OTPs. Loosening That Rule Is Dividing Providers — Behavioral Health Business · U.S. industry trade publication serving behavioral health operators
- Sens. Markey, Paul Reintroduce Legislation to Modernize Rules for Treating Opioid Use Disorder — Office of U.S. Senator Ed Markey · Democratic U.S. senator's official communications; bill is bipartisan with Sen. Rand Paul (R-KY)
- A New Methadone Playbook: How DOGE and Deregulation Can Save Lives — Cato Institute · U.S. libertarian think tank; Koch-linked founding and donor base
- Maine drug overdoses are down. Is Vance right that Trump's border policies are the cause? — PolitiFact · U.S. center-left fact-checking project of the Poynter Institute
- Asheboro Clinic Becomes NC's 100th Opioid Treatment Site as Overdose Deaths Plunge — Hoodline · U.S. local news aggregator using AI-assisted summarization of press releases